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eAssociated Radiologists, Saskatoon, Saskatchewan, CanadaAbstractIntroduction: To assess the incidence and clinical significance of pneumoperitoneum after radiologic percutaneous gastrojejunostomy (PGJ)
tube insertion.
Methods: Sixteen subjects were prospectively assessed after imaging-guided PGJ tube insertion to discern the incidence of pneumo-
peritoneum related to specific clinical signs and symptoms. Computed tomography of the abdomen and the pelvis was performed imme-
diately after PGJ insertion. A clinical evaluation, including history, general and abdominal physical examination, temperature, complete
blood cell count, abdominal pain, and abdominal tension, was performed on days 1 and 3, and at the discretion of the nutritional support team
on day 7 after PGJ insertion.
Results: Fifteen of the 16 subjects demonstrated imaging findings of pneumoperitoneum after the PGJ-tube insertion. Only a small amount of
pneumoperitoneum was demonstrated in 10 of the subjects, whereas a large volume of gas was detected in 2 of the subjects. The only altered
clinical findings encountered were increased white blood cell count and fever. These abnormal clinical data were most frequently seen
immediately after feeding-tube placement.
Discussion: Pneumoperitoneum was a common finding after PGJ-tube placement in our study population. There were no statistically
significant abnormal clinical parameters, in the presence or absence of pneumoperitoneum, for any of the subjects after PGJ-tube insertion.
Conservative management of pneumoperitoneum after PGJ is warranted.ResumeIntroduction : Evaluer l’incidence et l’importance clinique d’un pneumoperitoine qui survient a la suite de l’insertion d’un tube de gastro-
jejunostomie percutanee guidee par radioscopie.
Methodes : Seize sujets ont subi une evaluation prospective a la suite de l’insertion d’un tube de gastro-jejunostomie percutanee guidee par
radioscopie afin de determiner l’incidence d’un pneumoperitoine lie a des signes et a des sympto^mes cliniques precis. Une tomodensitometrie
(TDM) de l’abdomen et du bassin a ete realisee immediatement apres l’insertion du tube de gastro-jejunostomie percutanee. Une evaluation
clinique, y compris l’examen des antecedents medicaux, un examen physique general, un examen de l’abdomen, la prise de la temperature, la
numeration globulaire complete, l’evaluation des douleur et tension abdominales, ont ete effectues au premier et au troisieme jours, et a la
discretion de l’equipe de soutien nutritionniste au septieme jour suivant l’insertion du tube.
Resultats : La TDM de 15 des 16 sujets a permis d’observer un pneumoperitoine a la suite de l’insertion d’un tube de gastro-jejunostomie
percutanee. Seul un faible volume de pneumoperitoine a ete observe chez 10 des sujets, alors qu’un grand volume de gaz a ete decele chez
deux des sujets. Les seules donnees cliniques alterees de l’etude concernaient le nombre accru de globules blancs et la fievre. Ces donnees
cliniques anormales ont le plus souvent ete observees immediatement apres la mise en place du tube d’alimentation.Disclosures: Brent Burbridge has been engaged by Cook Canada Inc to
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jejunostomie percutanee. D’un point de vue statistique, les sujets ne presentaient pas de parametres cliniques anormaux importants, en
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Percutaneous gastrojejunostomy (PGJ), for alimentation, is percutaneous nutritional supplementation. Subject exclusion
the preferred radiologically implanted feeding tube for our
patient population. We encountered a patient with asymp-
tomatic pneumoperitoneum 2 days after PGJ-tube placement
and embarked upon this study to determine the frequency and
clinical significance of this finding in a cohort of patients.
Imaging of the abdomen for the detection of pneumo-
peritoneum can be performed by using both plain radiographs
and computed tomography (CT), but it is evident that CT
imaging is capable of detecting this complication more
accurately than abdominal radiographs [1,2].
Wojtowycz et al [3] demonstrated the presence of pneu-
moperitoneum after the insertion of percutaneous gastrostomy
tubes in their interventional suite. Chishty et al [4] also noted
the occurrence of pneumoperitoneum after radiologic gas-
trostomy. However, neither of these researchers performed
detailed imaging of all of their subjects nor did they evaluate
specific clinical parameters to determine the significance of
this postprocedural finding. Wojtowycz et al [3] suggests that,
after percutaneous gastrostomy, pneumoperitoneum should
only be of concern if it increases in size.
Dewald et al [5], in discussing their experience with 701
fluoroscopically guided gastrostomies or gastrojejunostomies
when using a gastropexy device, made no comment about the
incidence of pneumoperitoneum after feeding-tube insertion.
They domention a patient who experienced tube dislodgement
and pneumoperitoneum 9 months after feeding-tube place-
ment but no documented evidence of pneumoperitoneum in
the immediate postprocedural period. Likewise, there was no
mention of pneumoperitoneum as a complication in articles by
Friedman et al [6] and Yip et al [7].
To our knowledge, the presence of pneumoperitoneum
after PGJ-tube placement, correlated with the clinical rele-
vance of this complication, has not been evaluated. This
prospective study was carried out as a collaborative effort
between the Medical Imaging Department and the Depart-
ment of Surgery, Nutritional Support Service, to evaluate the
incidence of and the clinical relevance of pneumoperitoneum
after PGJ-tube insertion.
Methods
The University of Saskatchewan Biomedical Research
Ethics Board assessed and approved this research project.
Informed consent for both the feeding-tube procedure and for
entry into the research study was obtained from the subject
or the subject’s designate. Twenty-one consecutive patients
were enrolled in this project. All the subjects requiredcriteria included the following: age younger than 16 years,
pregnancy, an inability to obtain consent, a history of
complicated gastric or biliary surgery, distorted stomach or
small-bowel anatomy, an inability to access the stomach for
tube insertion, and coagulation disorders. Imaging data, to
detect the incidence of pneumoperitoneum, were collected
on day 1 after PGJ-tube insertion. Full clinical assessment
was performed on day 1 and day 3, and at the discretion of
the Nutritional Support Service team on day 7, without any
further imaging acquired.
Of the 21 subjects enrolled, 16 subjects were included in
the final data analysis. One of the subjects died, unrelated to
the interventional procedure, 3 subjects were discharged
before completion of the data collection, and insufficient data
collection occurred for 1 inpatient, and this individual was
excluded from further analysis. There were 7 women and
9 men, ranging in age from 17-84 years. The clinical scenarios
that resulted in PGJ-tube insertion for this group were the
following: stroke or intracranial hemorrhage in 7 subjects,
head and neck malignancy in 3, trauma in 3, complicated
pancreatitis in 2, and an aortic dissection in 1 subject. All the
study subjects were reviewed by the interventional radiology
team and by the nutritional support clinical team to ensure that
there were no contraindications for PGJ-tube insertion. The
nutritional support team consisted of a single supervising
surgeon and a dedicated team nurse.
The day before the PGJ procedure, a nasogastric tube was
inserted, and the subjects were to have nothing by mouth
after midnight. The evening before PGJ-tube insertion,
water-soluble contrast was given to the subjects via the
nasogastric tube, which allowed for fluoroscopic visualiza-
tion of the colon at the time of PGJ-tube placement and did
not cause an artifact on the subsequent CTs of the abdomen.
At the time of PGJ-tube insertion, an abdominal ultra-
sound was used to localize and mark the boundaries of the
liver. An anterior abdominal-wall puncture site was chosen
lateral to the rectus muscle to avoid the liver and colon.
The abdomen puncture site was prepared by using sterile
technique, and 1% lidocaine was used for abdominal-wall
anaesthesia. Conscious sedation was not used. The stomach
was inflated with between 300 and 1500 mL of hand-injected
room air via the nasogastric tube. Under fluoroscopic guid-
ance, the stomach was punctured with a 12-cm-long, 17-gauge
needle, preloaded with a single Cope Gastrointestinal Suture
Anchor (Cook Medical, Mississauga, ON) [8]. Before
deployment of the Cope retention suture, confirmation of
appropriate placement of the needle in the stomach was
Table 1
The point prevalence and size (cm3) of subjects’ pneumoperitoneum
immediately after percutaneous gastrojejunostomy
Event
No pneumoperitoneum, n (%) 1 (6.3)
Small (1-150 cm3), n (%) 10 (62.5)
Medium (151-350 cm3), n (%) 3 (18.8)
Large (351-3000 cm3), n (%) 2 (12.5)
n ¼ the number of subjects.
Table 2
The point prevalence of the most commonly reported clinical signs and
symptoms (of the 6 measured: abdominal pain, abdominal tension, vomiting,
diarrhoea, fever, and increased WBC count) 1, 3, 7 days after percutaneous
gastrojejunostomy
Event Day 1 Day 3 Day 7
Total no. patients 16 16 10
Abdominal pain, n 0 0 0
Abdominal tension, n 0 0 0
Vomiting, n 0 0 0
Diarrhoea, n 0 0 0
Fever, n (%) 0 2 (12.5) 0
Increased WBC count, n (%) 8 (50) 3 (18.8) 2 (20)
n ¼ number of subjects; WBC ¼ white blood cell.
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Optiray 320 (ioversol) (Tyco Healthcare, Montreal, QC). A
single Cope retention suturewas deployed in the stomach. The
puncture needle was removed over the guidewire, the gas-
tropexy was pulled taut, and the suture was anchored to the
skin. Subsequently, a 5F dilator was placed into the stomach
over the 75-cm-long guidewire. The original guidewire was
exchanged for a 145-cm, 0.035-inch, Amplatz wire guide,
(Cook Medical).
The initial 5F dilator was exchanged for a 5F angio-
graphic catheter, of the operator’s preference, and the
catheter and guidewire combination were manipulated
beyond the ligament of Trietz. The tract was dilated to 12F
and a 12F PGJ catheter (Cook Medical) was positioned with
the distal tip beyond the ligament of Trietz. The design and
deployment of this PGJ tube is discussed in Burbridge et al
[9]. The position of the distal end of the PGJ tube in the
proximal jejunum was confirmed by injection of water-
soluble contrast. Orders were left for the subjects to
continue to have nothing by mouth until PGJ-tube feeding,
which was previously approved by the Nutritional Support
Service team. The PGJ-tube placements were technically
successful in all 21 initial research subjects, with no
unexpected technical difficulties or complications encoun-
tered in the study group. CT of the entire abdomen and
pelvis was obtained after PGJ-tube insertion. These exam-
inations were performed without intravenous or oral
contrast agents.
Three radiologists not involved in the study and blinded to
the clinical status were asked to assess the CTs for the
presence of pneumoperitoneum. If free intraperitoneal gas
was detected on the CT images, then a volume of the largest
intraperitoneal gas collection was calculated. The gas
collections detected were graded as small, medium, or large,
as follows: 0, no sign of pneumoperitoneum; 1, ‘‘small’’
(1-150 cm3); 2, ‘‘medium’’ (151-350 cm3); and 3, ‘‘large’’
(351-3000 cm3).
Clinical evaluations, including history, physical exami-
nation of the subject in general and specifically of the
abdomen, and laboratory investigations were collected by the
Nutritional Support Service on days 1 and 3. Clinical
assessment on day 7 was optional at the discretion of the
nutritional support team. This assessment specifically asked
about symptoms of abdominal pain or abdominal tension.
In addition, the patient’s temperature and complete blood
cell count were analysed, and the presence or absence of
vomiting and/or diarrhoea was documented.
The clinical symptoms of abdominal pain and abdominal
tension, and the following clinical signs of vomiting, diar-
rhoea, fever, or increased white blood cell (WBC) count,
at any time point in the study period, were checked for inde-
pendence from pneumoperitoneum by using the Fisher exact
test. The Spearman correlation coefficient (rs) quantified the
magnitude and direction of any potential relationship between
the number of symptoms or signs that a subject experienced
and the average size of any pneumoperitoneum observed. All
statistical analyses were performed at a 5% level ofsignificance by using SPSS Statistical Software for Windows
(SPSS Inc, Chicago, IL).
Results
Pneumoperitoneum was demonstrated on 15 of 16 CTs
(93.7%) obtained immediately after PGJ (Table 1). CT
imaging for 2 subjects (12.5%) demonstrated a ‘‘large’’
pneumoperitoneum (>351-3000 cm3). Throughout the
follow-up period, aberration of only WBC count and body
temperature were detected. On day 1, approximately 8 of
16 subjects (50%) had evidence of increased serum WBC
count. The number of subjects with an increased WBC count
declined to 3 of 16 (19%) at day 3. The only other abnormal
sign encountered was fever in 2 of 16 subjects (12.5%) on day
3 (Table 2). The results of testing for an association between
the presence of pneumoperitoneum and the occurrence of any
of the 6 clinical signs or symptoms are presented in Table 3. At
each time point (days 1, 3, and 7), the presence of pneumo-
peritoneum was not significantly associated with presenting
clinical signs or symptoms (P values were all greater than
.05). No significant correlation between the number of signs
or symptoms and the presence of pneumoperitoneum was
observed for the study period (rs ¼ e0.265, P ¼ .46).
Discussion
Our study, although limited by our cohort size, shows that
pneumoperitoneum is a very common finding after PGJ-tube
placement. There were no statistically significant clinical
signs or symptoms for any of the subjects after PGJ-tube
insertion. The only signs encountered were asymptomatic,
transient, mildly increased WBC count and body tempera-
ture, and these were found to not be statistically significant.
Table 3
Statistical comparison of the presence of pneumoperitoneum with the
prevalence of any of the 6 clinical signs or symptoms (combined) at day 1, 3,
and 7 during the follow-up period
Day 1 Day 3 Day 7
Any sign or symptom at day 1, n 8
Any sign or symptom at day 3, n 5
Any sign or symptom at day 7, n 2
P values were all greater than .05. Significance levels are based on the Fisher
exact test.
n ¼ number of subjects.
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postprocedure time frame and resolved quickly.
The detection of bowel perforation and peritonitis in the
patient population that requires percutaneous gastrostomy or
PGJ may be complicated by neurologic or clinical conditions
that obscure the classic physical findings of these complica-
tions. There are no pertinent references to studies related to
radiologically implanted gastrojejunostomy tubes that
specifically discuss the frequency and management of post-
implantation pneumoperitoneum.
Milanchi and Allins [10] found 4 of 85 patients (5%) who
demonstrated pneumoperitoneum on upright chest radio-
graphs after endoscopically guided gastrostomy. They noted
that the only patient of this group of 4 who demonstrated
a persistent pneumoperitoneum and a volume of gas consid-
ered to be ‘‘large,’’ after 3 days of observation, was proven by
CT to have a transcolonic placement of the feeding tube. They
stated, ‘‘Presence of pneumoperitoneum should alert clini-
cians to the possibility of iatrogenic bowel injury, especially in
cases in which pneumoperitoneum does not resolve over time
(in our series, 72 hours) or is thought to be significant (in our
institution, defined as subdiaphragmatic air pockets larger
than 2 cm) [10].’’
Fluoroscopically guided gastrojejunostomy-tube insertion
should greatly minimize, although not entirely eliminate, therisk of transcolonic-tube placement and, therefore, diminish
suspicion for pneumoperitoneum related to this complication.
Although common, pneumoperitoneum is a clinically benign
finding after fluoroscopically guided gastrojejunostomy. All
of the subjects in our study were managed conservatively and
did not demonstrate any negative sequelae of this finding
detected on abdominal CT.References
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